Skip to main content

Advertisement

SpringerLink
Log in

Validated method for occupational cyclophosphamide monitoring using LC-MS/MS and a Poroshell 120 column

  • Original Paper
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

Pharmacy staff and health care workers in hospitals may be exposed to antineoplastic drugs during cancer chemotherapy. Sensitive methods should be used to monitor the occupational exposure in biofluids such as urine. In this study, a sensitive method for cyclophosphamide determination in urine with high recovery was developed and validated for monitoring occupational exposure. Triple liquid-liquid extraction with ethyl acetate/dichloromethane (φr= 3:1; 6.0 mL) was applied. Good separation of cyclophosphamide and ifosfamide was achieved in a 9.0 min analysis, using liquid chromatography combined with tandem mass spectrometry (LC-MS/MS). Limit of detection and limit of quantification were 0.07 ng mL−1 and 0.11 ng mL−1, respectively. Repeatability (RSD, %) was ≤ 12.74%. Inter-day and inter-analyst precision values (RSD, %) were ≤ 13.94% and 12.59%. Mean recovery for three different concentrations was (101.62 ± 6.05) %. The validation results were fitted for the purpose of routine monitoring of occupational cyclophosphamide exposure in hospital staff.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • AOAC International (2012). Appendix F: guidelines for standard method performance requirements. Retrieved June 2, 2015, from http://www.eoma.aoac.org/app_f.pdf

  • B’Hymer, C., & Cheever, K. L. (2010). Evaluation of a procedure for the simultaneous quantification of 4-ketocyclophosphamide, cyclophosphamide, and ifosfamide in human urine. Journal of Chromatographic Science, 48 328–333. DOI: 10.1093/chromsci/48.5.328.

    Article  Google Scholar 

  • Cserháti, T., & Szögyi, M. (2013). Chromatography of anti-cancer drugs. European Chemical Bulletin, 2 715–721.

    Google Scholar 

  • Dhakane, V. D., & Ubale, M. B. (2013). Development and validation of a reverse phase high performance liquid chromatographic method for the estimation of cyclophosphamide in bulk drug. International Journal of Pharmacy & Pharmaceutical Sciences, 5 184–187.

    CAS  Google Scholar 

  • Eisenberg, S. (2009). Safe handling and administration of antineoplastic chemoterapy. Journal of Infusion Nursing, 32 23–32. DOI: 10.1097/nan.0b013e31819246e0.

    Article  Google Scholar 

  • Eurachem (1998). The fitness for purpose of analytical methods: a laboratory guide to method validation and related topics. Retrieved June 2, 2015, from http://eurachem.org/images/stories/Guides/pdf/valid.pdf

  • Fransman, W., Kager, H., Meijster, T., Heederik, D., Kromhout, H., Portengen, L., & Blaauboer, B. J. (2014). Leukemia from dermal exposure to cyclophosphamide among nurses in the Netherlands: Quantitative assessment of the risk. The Annals of Occupational Hygiene, 58 271–282. DOI: 10.1093/annhyg/met077.

    Article  CAS  Google Scholar 

  • Hedmer, M., Georgiadi, A., Bremberg, E. R., Jönsson, B. A. G., & Eksborg, S. (2005). Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Annals of Occupational Hygiene, 49 629–637. DOI: 10.1093/annhyg/mei042.

    Article  CAS  Google Scholar 

  • Hirst, M., Mills, D., Tse, S., Levin, L., & White, D. F. (1984). Occupational exposure to cyclophosphamide. The Lancet, 323 186–188. DOI: 10.1016/s0140-6736(84)92111-1.

    Article  Google Scholar 

  • Ghante, M. R., Pannu, H. K., Loni, A., & Shivsharan, T. (2012). Development and validation of a RP-HPLC method for simultaneous estimation of metronidazole and norfloxacin in bulk and tablet dosage form. International Journal of Pharmacy & Pharmaceutical Sciences, 4 241–245.

    CAS  Google Scholar 

  • Karahalil, B., & Akkoyunlu, K. I. (2003). Determination of urinary cyclophosphamide in oncology nurses handling antineoplastic drugs by gas chromatography-mass spectrometry. FABAD Journal of Pharmaceutical Sciences, 28 125–130.

    CAS  Google Scholar 

  • Kasel, D., Jetter, A., Harlfinger, S., Gebhardt, W., & Fuhr, U. (2004). Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 18 1472–1478. DOI: 10.1002/rcm.1508.

    Article  CAS  Google Scholar 

  • Minioa, C., Turci, R., Sottani, C., Schiavi, A., Perbellini, L., Angeleri, S., Draicchio, F., & Apostoli, P. (1998). Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Communications in Mass Spectrometry, 12 1485–1493. DOI: 10.1002/(SICI)1097-0231(19981030)12:20<1485∷AID-RCM333>3.0.CO;2-N.

    Article  Google Scholar 

  • Mocak, J., Bond, A. M., Mitchell, S., & Scollary, G. (1997). A statistical overview of standard (IUPAC and ACS) and new procedures for determining the limits of detection and quantification: application to voltammetric and stripping techniques. Pure and Applied Chemistry, 69 297–328. DOI: 10.1351/pac199769020297.

    Article  CAS  Google Scholar 

  • Pethran, A., Schierl, R., Hauff, K., Grimm, C. H., Boos, K. S., & Nowak, D. (2003). Uptake of antineoplastic agents in pharmacy and hospital personel. Part 1: Monitoring of urinary concentration. International Archives of Occupational and Environmental Health, 76 5–10. DOI: 10.1007/s00420-002-0383-8.

    CAS  Google Scholar 

  • Rekhadevi, P. V., Sailaja, N., Chandrasekhar, M., Mahboob, M., Rahman, M. F., & Grover, P. (2007). Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis, 22 395–401. DOI: 10.1093/mutage/gem032.

    Article  CAS  Google Scholar 

  • Rivera, C., & Rodríguez, R. (2014). Horwitz equation as quality benchmark in ISO/IEC 17025 testing laboratory. Retrieved June 2, 2015, from http://www.bii.mx/documentos/horwitzCf11.pdf

  • Ruta, J., Zurlino, D., Grivel, C., Heinisch, S., Veuthey, J. L., & Guillarme, D. (2012). Evaluation of columns packed with shell particles with compounds of pharmaceutical interest. Journal of Chromatography A, 1228 221–231. DOI: 10.1016/j.chroma.2011.09.013.

    Article  CAS  Google Scholar 

  • Sato, J., Mori, M., Sasaki, T., Nihei, S., Kumagai, M., Nakayama, S., & Kudo, K. (2014). Field survey of the anti-cancer drug contamination in the preparation environment-usefulness of the 5-FU monitoring by the coupon method. Journal of the Pharmaceutical Society of Japan, 134 751–756. DOI: 10.1248/yakushi.13-00154.

    CAS  Google Scholar 

  • Schreiber, C., Radon, K., Pethran, A., Schierl, R., Hauff, K., Grimm, C. H., Boos, K. S., & Nowak, D. (2003). Uptake of antineoplastic agents in pharmacy personnel. Part II: study of work-related risk factors. International Archives of Occupational and Environmental Health, 76 11–16. DOI: 10.1007/s00420-002-0385-6.

    CAS  Google Scholar 

  • Sertler, S. (2013). Assessment of the safe working condition of the healthcare personnel with antineoplastic drugs and biological and environmental contamination, Ph.D. Thesis, University of Istanbul, Istanbul, Turkey.

    Google Scholar 

  • Sessink, P. J. M., Cerná, M., Rössner, P., Pastorková, A., Bavarová, H., Franková, K., Anzion, R. B. M., & Bos, R. P. (1994). Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 309 193–199. DOI: 10.1016/0027-5107(94)90092-2.

    Article  CAS  Google Scholar 

  • Sottani, C., Turci, R., Perbellini, L., & Minioa, C. (1998). Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 12 1063–1068. DOI: 10.1002/(SICI)1097-0231(19980831)12:16<1063∷AID-RCM287>3.0.CO;2-K.

    Article  CAS  Google Scholar 

  • Sottani, C., Tranfo, G., Faranda, P., & Minoia, C. (2005). Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents. Rapid Communications in Mass Spectrometry, 19 2794–2800. DOI: 10.1002/rcm.2116.

    Article  CAS  Google Scholar 

  • Sottani, C., Rinaldi, P., Leoni, E., Poggi, G., Teragni, C., Delmonte, A., & Minoia, C. (2008). Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: Bioanalytical method validation. Rapid Communications in Mass Spectrometry, 22 2645–2659. DOI: 10.1002/rcm.3657.

    Article  CAS  Google Scholar 

  • Tanimura, M., Yamada, K., Sugiura, S. I., Mori, K., Nagata, H., Tadokoro, K., Miyake, T., Hamaguchi, Y., Sessink, P., & Nabeshima, T. (2009). An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer. Journal of Health Science, 55 750–756. DOI: 10.1248/jhs.55.750.

    Article  CAS  Google Scholar 

  • Ziegler, E., Mason, H. J., & Baxter, P. J. (2002). Occupational exposure to cytotoxic drugs in two UK oncology wards. Occupational and Environmental Medicine, 59 608–612. DOI: 10.1136/oem.59.9.608.

    Article  CAS  Google Scholar 

  • Zhang, J., Tian, Q., & Zhou, S. F. (2006). Clinical pharmacology of cyclophosphamide and ifosfamide. Current Drug Therapy, 1 55–84. DOI: 10.2174/157488506775268515.

    Article  CAS  Google Scholar 

  • Zhou, J. Y., Gao, S. H., Zhang, F., Jiang, B., Zhan, Q., Cai, F., Li, J. X., & Chen, W. S. (2012). Liquid chromatography-tandem mass spectrometry method for simultaneous determination of seven commonly used anticancer drugs in human plasma. Journal of Chromatography B, 906 1–8. DOI: 10.1016/j.jchromb.2012.07.033.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istanbul University Institute of Forensic Sciences, Cerrahpasa/Istanbul, 34300, Turkey

    Beril Anılanmert, Fatma Cavus & Salih Cengiz

  2. Turkish Council of Forensic Medicine, Yenibosna/Istanbul, 34186, Turkey

    Sefika Sertler

Authors
  1. Beril Anılanmert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sefika Sertler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatma Cavus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salih Cengiz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beril Anılanmert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anılanmert, B., Sertler, S., Cavus, F. et al. Validated method for occupational cyclophosphamide monitoring using LC-MS/MS and a Poroshell 120 column. Chem. Pap. 69, 1395–1401 (2015). https://doi.org/10.1515/chempap-2015-0157

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1515/chempap-2015-0157

Keywords

Search

Navigation